Phenylbut-3-en-2-one Derivatives, Anticandidial, Ergosterol, UV Spectroscopy This paper reports the effect of phenylbut-3-en-2-one, of its analogues, bearing 3-nitro, 4-nitro, 4-chloro-and 4-dimethylamino substituents at the phenyl moiety, and of the hydrazide, phenylhydrazide and oxime of 4-nitrophenylbut-3-en-2-one on the growth and germ-tube formation of Candida spp., as well as their ability to interact with ergosterol in water/dimethylformamide (DMF) solution and their acute toxicity for mice. 3-Nitro-, 4-nitro-and 4-chlorophenylbut-3-en-2-ones inhibit candidial growth in vitro in concentrations ranging from 0.01 to >0.4 mM and their activity is comparable to that of ketoconazole (in mg/1) and lower than that of amphotericin B. The rest of the compounds are inactive at >0.4 mM. G erm -tube form a tion of C.albicans is inhibited at 0.04 mM 4-nitrophenylbut-3-en-2-one and at 0.005 mM of the 3-nitro isomer. A decrease in the absorption maxima in ergosterol mixtures with 4-dimethyl amino, 3-nitrophenylbut-3-en-2-one and the oxime of the 4-nitrophenylbut-3-en-2-one was observed, indicative of interaction in water/DM F solutions, while no changes in the UV spectra of the remaining compounds were detectable. That suggests that the growth inhibiting effect is not in correlation with their ability to interact with ergosterol, despite the resem blance to polyenes. LD50 for mice is 367 mg/kg for 4-nitrophenylbut-3-en-2-one and 398 mg/ kg for the 3-nitro isomer.
The increase in the incidence of infections, caused by yeast-like fungi from species Candida (Pfaller, 1994; Miller and Wenzel, 1987) , the emerging of strains resistant or cross-resistant towards currently available drugs (e.g. 5-fluorocytosine, fluconazole, (Speller and Davis, 1972, Nolte et al., 1997) ), the narrow therapeutic index of agents for the treatment of systemic infections (e.g. amphotericin B, 5-fluorocytosine (Jullien et al., 1990) ), as well as the low serum concentrations of some azole derivatives prom pted the search for anticandidial drugs for either systemic or local ap plication, belonging to new chemical classes (Graybill, 1992) .
We were interested in the anticandidial effect of a series of phenylbutene derivatives, a group of Reprint requests to Dr. Svoboda Tabakova, Institute of Molecular Biology, Acad. G. Bonchev str. Bl. 21, 1113 Sofia, Bulgaria. E-mail: svt@bas.bg compounds that have a system of conjugated double bonds in which the delocalised pi-electrons originate both from the aliphatic chain and the benzene ring. It was previously reported that some of them (4-nitro-and 3-nitrophenylbut-3-en-2-one) exhibit an antibacterial effect and inhibit pro tein synthesis in E. coli (Tabakova et al., 1994) . These two nitro derivatives were also effective against S. cerevisiae (Tabakova, unpublished data) and it was expected that they may act against yeast-like fungi as well. Since the nitrophenylbutenones did not affect protein synthesis in the yeast strains it was obvious that the mechanisms of growth inhibition in bacteria and baker's yeasts would be different. The unsaturated character of the phenylbutene derivatives makes them similar to pecilocin -a polyene antibiotic (Reiner, 1982) and one possibility is that the phenylbutenes in teract with ergosterol and that the anti-yeast effect of this series is associated with the unsaturated character of the molecule. To the best of our knowledge, the anticandidial effect of phenylbutene derivatives has not been in vestigated so far and the objective of this work is to compare the anticandidial effect of phenylbu tene derivatives with different num ber of conju gated double bonds and substituents and their ability to interact with ergosterol, as determ ined by UV absorption spectra.
For this purpose we have determ ined in vitro the minimal inhibitory concentration (MIC) of phenylbut-3-en-2-ones, with different substituents at the phenyl ring and of the hydrazide, phenylhydrazide and oxime derivatives of 4-nitrophenylbut-3-en-2-one for standard strains of Candida spp. and clinical isolates from patients and their ability to interact with ergosterol in solution. The results are presented in Table I . The effect of 4-nitrophenylbut-3-en-2-one on germ tube formation in C.albicans was studied, as well as the acute toxicity of the compound for mice.
The MIC values presented in Table I are the m ean ± SD for the strains taken from three inde pendent experiments and the range.
Only the nitro-and chlorosubstituted ana logues were effective in concentration of 0.4 mM or lower, while the unsubstituted and dimethylamino substituted compounds had no antican didial effect. The concentration of the com pounds that inhibited the formation of germ tubes for C. albicans ATCC 90028 strain is 0.04 mM for 4-nitrophenylbut-3-en-2-one and 0.005 mM for the 3-nitroanalogue. Table I . Interaction with ergosterol (decrease in the specific sterol absorption maxima) and the minimal inhibitory concentrations in mM (mean ± SD and range) o f phenylbutene derivatives. It appears that the antifungal activity of the compounds is associated with the different distri bution of the electronic density at the aromatic ring, rather than with the number of conjugated double bonds p er se, since the chlorosubstituted analogue was insignificantly less active than the nitroderivatives.
Increasing the number of double bonds by derivatisation of the aliphatic chain decreased the an ticandidial effect and in fact only the carbonyl de rivatives were active.
The UV spectra of the compounds in ergosterol solution indicated that only the 3-nitrophenylbut-3-en-2-one, the 4-dimethylaminophenylbut-3-en-2-one (Fig. 1.) and the oxime of the 4-nitrophenylbut-3-en-2-one (decrease of the specific absorption maxima of ergosterol at 261, 271, 281 or 295 nm and amphotericin B (decrease in the ratio of ab sorption of the characteristic peaks of am photeri cin B - Fig. 2 .) interacted under these conditions. There was no correlation between the anticandid ial effect of the phenylbutene derivatives and their behaviour in ergosterol mixtures, which makes un likely our initial hypothesis that they act similarly to polyenes.
There are data that nitro-and chlorosubstituted phenyls are substrates for mammalian CYP 450 and beta unsaturated ketones are substrates for mammalian glutathione-S-transferases (Boobis et al., 1989) . Assuming that Candida has biotransfor mation enzymes with analogous substrate specifi cities, it may be suggested that the toxicity for fungi of the nitro-and chlorosubstituted phenylbut-3-en-2-ones is produced by mechanisms, sim- ilar to those of cellular toxicity. Investigations to verify this hypothesis have started and will be re ported in a separate article.
The nitro-and chlorophenylbut-3-en-2-ones have an activity (in mg/1) similar to that of ketoconazole, but are less active than amphotericin B. However, the LD 50 for mice of the 3-and 4-nitrophenylbut-3-en-2-ones (398 and 367 mg/kg after Wavelength (nm) Fig. 1 . UV absorption spectra of ergos terol 0.05 itim(---------), 4-nitrophenylbut-2-en-3-one alone 0.2 mM (-xxxx...... ), ergosterol (0.05 mM) in mixture with 4-nitrophenylbut-2-en-3-one (0.20 mM) (-x-xx-x-) The UV ab sorption of the mixture is equal to the sum of the absorption of the compo nents and indicates no interaction be tween the components. 4-dimethylaminophenylbut-2-en-3-one (0.2 mM) (-----) interacts with ergosterol (0.05 mM), as indicated by the decrease at one of the specific maxima for ergos terol at 295 nm in the absorption spectrum of the mixture (---).
intraperitoneal application, respectively) is con siderably lower than that for amphotericin B (6 mg/kg (Reiner, 1982) ). The fact that they are also effective against bacteria may make them use ful in mucocutaneal candidiasis or mixed infec tions.
Experimental

Compounds:
The structural formulae of the compounds are given in Table I and the synthesis and identification was carried out as described previously (Tabakova et al., 1994) . Ketoconazole and amphotericin B were commercial products. Standard Candida strains are listed in Table I and clinical isolates were from adult patients with a mucocutaneal form of the disease. The strains were characterised to subspecies by their ability to metabolise carbohydrates, as described by Baker (1967) .
The growth-inhibiting effect of the phenylbutene derivatives has been assessed in vitro by the minimal inhibitory concentration (MIC) of the compounds, determ ined by the m icrotitre broth dilution method (Radetsky et al., 1986) in Sabouraud broth with 1% glucose. MICs are equal to the lowest concentration of the compound, at which no visually detectable growth occurred after a 48-h incubation at 30 °C. In brief, the compounds were dissolved in a small volume of ethanol and these solutions were further diluted with the re spective nutrient medium, the concentration of ethanol being less than 1 % in the final dilutions. 0.1 ml aliquots of the drug-containing media were dispatched in the wells. Inoculation was carried out by adding to each of the wells 0.1 ml suspen sion of the respective Candida strain, containing 0 .5 -lx l0 5 culture forming units(cfu)/ml. The sus pensions were prepared by diluting overnight cul tures of the yeast-like fungi to an optical density of 0.125 (0.5 McFarlan standard) by adding sterile medium and subsequent 10 -fold dilution.
Effect on germ-tube formation: Candida albicans strains were inoculated (lxlO6 cfu/ml) in TC 199 medium (Difco) containing different concentra tions of the drugs. After 4 -6 h of incubation at 30 °C the presence of germ-tubes was determined microscopically and recorded.
Interaction with ergosterol was studied as de scribed by Norman et al. (1972) . Solutions of ergosterol, the phenylbutene analogues and mixtures of ergosterol and the respective phenyl butene derivatives were prepared in 0.1 ml dimethylformamide (DM F), diluted to 2 ml with dis tilled water and were left to stand for 30 min. The UV spectra were recorded on a Beckman DU-600 and were compared.
Acute toxicity of the compounds was deter mined after intraperitoneal application for mice, using the LD 50 criterion.
